MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months |
|---|---|
| Revenue | $618M |
| Operating income | −$834M |
| Net income | −$860M |
| EPS | −$14.57 |
| Free cash flow | −$229M |
Mirum Pharmaceuticals, Inc.
$82.93−0.99 (−1.18%)Close Oct 2, 2026
| Metric | Last 12 months |
|---|---|
| Revenue | $618M |
| Operating income | −$834M |
| Net income | −$860M |
| EPS | −$14.57 |
| Free cash flow | −$229M |